Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 2/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 10/20 | 0.34 |
| ▸ | ACHE | P22303 | 6/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL31114401 | 1.00 | GPR3 (0.39) | GPR3KCNH2ACHEPTPN1 | |
| SCHEMBL8714768 | 0.84 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL8469662 | 0.84 | KCNH2 (0.35) | GPR3KCNH2ACHEPTPN1 | |
| Trifluoromethanesulfonic Acid SCHEMBL28565076 | 0.81 | ALDH1A1 (0.37) | PTPN1 | |
| SCHEMBL9174215 | 0.80 | NPSR1 (0.35) | — | |
| Trifluoromethanesulfonic Acid SCHEMBL1476918 | 0.79 | GPR3 (0.38) | GPR3KCNH2ACHEPTPN1 | |
| Trifluoromethanesulfonic Acid SCHEMBL29059560 | 0.79 | GPR3 (0.38) | GPR3KCNH2ACHEPTPN1 | |
| Trifluoromethanesulfonic Acid SCHEMBL321089 | 0.79 | KCNH2 (0.40) | GPR3KCNH2ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL10579458 | 0.79 | GPR3 (0.48) | GPR3KCNH2ACHEPTPN1 | |
| Trifluoromethanesulfonic Acid SCHEMBL160986 | 0.79 | GPR3 (0.48) | GPR3KCNH2ACHEPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 940 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559514-B2 | Synthesis of fluorinated nucleotides | MERCK SHARP & DOHME LLC (US) | 2026-02-24 | — | — | US | claimed |
| US-12506011-B2 | Methods for wet atomic layer etching of transition metal oxide dielectric materials | TOKYO ELECTRON LIMITED (JP) | 2025-12-23 | — | — | US | claimed |
| EP-4457212-B1 | METHOD FOR PREPARING IONIC COMPOUNDS | FUNDACION CENTRO DE INVESTIG COOPERATIVA DE ENERGIAS ALTERNATIVAS CIC ENERGIGUNE FUNDAZIOA (ES) | 2025-12-10 | — | — | EP | claimed |
| WO-2025245089-A1 | PROCESSES FOR PREPARING TETRALIN COMPOUNDS | ARCUS BIOSCIENCES, INC. (US) | 2025-11-27 | — | — | WO | claimed |
| WO-2025244956-A1 | METHODS OF MANUFACTURING DANICAMTIV | MyoKardia, Inc. (US) | 2025-11-27 | — | — | WO | claimed |
| EP-3504221-B1 | NOVEL PROCESS FOR PREPARATION OF CORTICOSTEROIDS | CORAL DRUGS PVT LTD (IN) | 2025-11-26 | — | — | EP | claimed |
| US-20250201572-A1 | METHODS FOR WET ATOMIC LAYER ETCHING OF TRANSITION METAL OXIDE DIELECTRIC MATERIALS | TOKYO ELECTRON LIMITED (JP) | 2025-06-19 | — | — | US | claimed |
| US-20250066294-A1 | METHOD FOR PREPARING IONIC COMPOUNDS | FUNDACIÓN CENTRO DE INVESTIGACIÓN COOPERATIVA DE ENERGÍAS ALTERNATIVAS CIC ENERGIGUNE FUNDAZIOA (ES) | 2025-02-27 | — | — | US | claimed |
| US-12145901-B1 | Process for preparing tetralin compounds | ARCUS BIOSCIENCES, INC. (US) | 2024-11-19 | — | — | US | claimed |
| US-11873289-B2 | Pyrazole compounds and preparation thereof | MyoKardia, Inc. (US) | 2024-01-16 | — | — | US | claimed |
| WO-2004016634-A1 | Novel 11,12-Substituted Lactone Ketolide Derivatives Having Antibacterial Activity | ENANTA PHARMACEUTICALS, INC. (US) | 2004-02-26 | — | — | WO | claimed |
| US-20030162959-A1 | Method for the preparation of 6alpha-fluoro corticosteroids | TARO PHARMACEUTICALS U.S.A., INC. | 2003-08-28 | — | — | US | claimed |
| WO-2003047329-A2 | METHOD FOR THE PREPARATION OF 6-ALPHA-FLUORO CORTICOSTEROIDS | TARO PHARMACEUTICALS U.S.A., INC. (US) | 2003-06-12 | — | — | WO | claimed |
| US-6365246-B1 | SOLUTION OR SLURRY SOLVENT ABSORBS HEAT OF VAPORIZATION FOR STABILITY OF QUATERNARY NITROGEN COMPOUNDS SUCH AS 1-CHLOROMETHYL-4-FLUORO-1,4-DIAZONIABICYCLO(2.2.2)OCTANE BIS(TETRAFLUOROBORATE) | AIR PRODUCTS AND CHEMICALS, INC. | 2002-04-02 | — | — | US | claimed |
| US-6124269-A | NOVEL ERYTHROMYCIN DERIVATIVE ANTIBIOTIC EFFECTIVE AGAINST GRAM-NEGATIVE BACTERIA AND HAVING LESS POTENTIAL FOR DEVELOPING BACTERIAL DRUG RESISTANCE | ABBOTT LABORATORIES (US) | 2000-09-26 | — | — | US | claimed |
| EP-1027362-A1 | 2-HALO-6-O-SUBSTITUTED KETOLIDE DERIVATIVES | Abbott Laboratories (US) | 2000-08-16 | — | — | EP | claimed |
| EP-0992494-A1 | Package for safe storage of electrophilic fluorinating agent | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2000-04-12 | — | — | EP | claimed |
| WO-1999021871-A1 | 2-HALO-6-O-SUBSTITUTED KETOLIDE DERIVATIVES | ABBOTT LABORATORIES (US) | 1999-05-06 | — | — | WO | claimed |
| US-5897940-A | Ink jet transparencies | XEROX CORPORATION (US) | 1999-04-27 | — | — | US | claimed |
| US-5336772-A | Reacting pyridine compound, fluorine and Bronsted acid in specified ratios | ONODA CEMENT CO., LTD. (JP) | 1994-08-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11873289-B2 | Pyrazole compounds and preparation thereof | TNNI3, TNNT2, HNRNPL | GPR3 2290/4885KCNH2 5/4885ACHE 4533/4885 |
| US-12145901-B1 | Process for preparing tetralin compounds | TFPI, TFPI2, F2 | GPR3 4881/4885KCNH2 1185/4885ACHE 1989/4885 |
| US-20030162959-A1 | Method for the preparation of 6alpha-fluoro corticosteroids | HSD3B1, CYP2F1, HSD3B2 | GPR3 628/4885KCNH2 2142/4885ACHE 1241/4885 |
| US-12559514-B2 | Synthesis of fluorinated nucleotides | NUDT1, NSUN2, PNP | GPR3 1241/4885KCNH2 383/4885ACHE 1747/4885 |
| US-20250066294-A1 | METHOD FOR PREPARING IONIC COMPOUNDS | TST, MRPS23, SRMS | GPR3 2247/4885KCNH2 201/4885ACHE 4044/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.